NeuroSense Therapeutics Ltd. (NRSN) has 12 identified peers for comparison in the Healthcare sector. Peers include ALLR, BDRX, BWV, HILS, KPRX, KRBP and others.
NRSN has a market capitalization of $18.01M, compared to an average peer market cap of $11.9M. NRSN is significantly larger than its average peer.
